Characterization of clinical Campylobacter jejuni isolates with special emphasis on lipooligosaccharide locus class, putative virulence factors and host response

International Journal of Medical Microbiology

Volumn 303, Issue 3, 2013, Pages 134-139

  Ellström, Patrik ^a   Feodoroff, Benjamin ^b   Hänninen, Marja Liisa ^c   Rautelin, Hilpi ^a,b,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Campylobacter; Clinical isolates; Host response; Lipooligosaccharide; Patient data; Sialic acid

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; INTERLEUKIN 8; LIPOOLIGOSACCHARIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; DISEASE SEVERITY; FECES CULTURE; GENE LOCUS; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IRON TRANSPORT; MAJOR CLINICAL STUDY; PREVALENCE;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CELL LINE; CIPROFLOXACIN; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; ENTERITIS; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; VIRULENCE FACTORS;

EID: 84875935946     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.01.005     Document Type: Article

References (33)

1. Bakhiet M., Al-Salloom F.S., Qareiballa A., Bindayna K., Farid I., Botta G.A. Induction of alpha and beta chemokines by intestinal epithelial cells stimulated with Campylobacter jejuni. J. Infect. 2004, 48:236-244.
2. Chen M.L., Ge Z., Fox J.G., Schauer D.B. Disruption of tight junctions and induction of proinflammatory cytokine responses in colonic epithelial cells by Campylobacter jejuni. Infect. Immun. 2006, 74:6581-6589.
3. CLSI Clinical and Laboratory Standards Institute Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline. In Clsi Document M45-A 2006, CLSI, Wayne, PA.
4. Dasti J.I., Tareen A.M., Lugert R., Zautner A.E., Gross U. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int. J. Med. Microbiol. 2010, 300:205-211.
5. de Zoete M.R., Keestra A.M., Roszczenko P., van Putten J.P. Activation of human and chicken Toll-like receptors by Campylobacter spp. Infect. Immun. 2010, 78:1229-1238.
6. Denis M., Soumet C., Rivoal K., Ermel G., Blivet D., Salvat G., Colin P. Development of a m-PCR assay for simultaneous identification of Campylobacter jejuni and C. coli. Lett. Appl. Microbiol. 1999, 29:406-410.
7. EFSA Panel on Biological Hazards Scientific opinion on Campylobacter in broiler meat production: control options and performance objectives and/or targets. EFSA J. 2011, 9:2105.
8. Fearnley C., Manning G., Bagnall M., Javed M.A., Wassenaar T.M., Newell D.G. Identification of hyperinvasive Campylobacter jejuni strains isolated from poultry and human clinical sources. J. Med. Microbiol. 2008, 57:570-580.
9. Feodoroff B., Ellström P., Hyytiäinen H., Sarna S., Hänninen M.L., Rautelin H. Campylobacter jejuni isolates in Finnish patients differ according to the origin of infection. Gut Pathogens 2010, 2:22.
10. Feodoroff B., Lauhio A., Ellström P., Rautelin H. A Nationwide Study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility. Clin. Infect. Dis. 2011, 53:e99-e106.
11. Feodoroff F.B., Lauhio A.R., Sarna S.J., Hänninen M.L., Rautelin H.I. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates. Clin. Microbiol. Infect. 2009, 15:188-192.
12. Gilbert M., Karwaski M.F., Bernatchez S., Young N.M., Taboada E., Michniewicz J., Cunningham A.M., Wakarchuk W.W. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J. Biol. Chem. 2002, 277:327-337.
13. Godschalk P.C., Kuijf M.L., Li J., St Michael F., Ang C.W., Jacobs B.C., Karwaski M.F., Brochu D., Moterassed A., Endtz H.P., van Belkum A., Gilbert M. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barré and Miller Fisher syndromes. Infect. Immun. 2007, 75:1245-1254.
14. Gonzalez I., Grant K.A., Richardson P.T., Park S.F., Collins M.D. Specific identification of the enteropathogens Campylobacter jejuni and Campylobacter coli by using a PCR test based on the ceuE gene encoding a putative virulence determinant. J. Clin. Microbiol. 1997, 35:759-763.
15. Habib I., Louwen R., Uyttendaele M., Houf K., Vandenberg O., Nieuwenhuis E.E., Miller W.G., van Belkum A., De Zutter L. Correlation between genotypic diversity, lipooligosaccharide gene locus class variation, and caco-2 cell invasion potential of Campylobacter jejuni isolates from chicken meat and humans: contribution to virulotyping. Appl. Environ. Microbiol. 2009, 75:4277-4288.
16. Hickey T.E., Baqar S., Bourgeois A.L., Ewing C.P., Guerry P. Campylobacter jejuni-stimulated secretion of interleukin-8 by INT407 cells. Infect. Immun. 1999, 67:88-93.
17. Johanesen P.A., Dwinell M.B. Flagellin-independent regulation of chemokine host defense in Campylobacter jejuni-infected intestinal epithelium. Infect. Immun. 2006, 74:3437-3447.
18. Koga M., Gilbert M., Takahashi M., Li J., Koike S., Hirata K., Yuki N. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barré syndrome after Campylobacter jejuni enteritis. J. Infect. Dis. 2006, 193:547-555.
19. Linton D., Owen R.J., Stanley J. Rapid identification by PCR of the genus Campylobacter and of five Campylobacter species enteropathogenic for man and animals. Res. Microbiol. 1996, 147:707-718.
20. Linton D., Lawson A.J., Owen R.J., Stanley J. PCR detection, identification to species level, and fingerprinting of Campylobacter jejuni and Campylobacter coli direct from diarrheic samples. J. Clin. Microbiol. 1997, 35:2568-2572.
21. Louwen R., Heikema A., van Belkum A., Ott A., Gilbert M., Ang W., Endtz H.P., Bergman M.P., Nieuwenhuis E.E. The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect. Immun. 2008, 76:4431-4438.
22. Mellits K.H., Mullen J., Wand M., Armbruster G., Patel A., Connerton P.L., Skelly M., Connerton I.F. Activation of the transcription factor NF-kappaB by Campylobacter jejuni. Microbiology 2002, 148:2753-2763.
23. Miller C.E., Williams P.H., Ketley J.M. Pumping iron: mechanisms for iron uptake by Campylobacter. Microbiology 2009, 155:3157-3165.
24. Mortensen N.P., Kuijf M.L., Ang C.W., Schiellerup P., Krogfelt K.A., Jacobs B.C., van Belkum A., Endtz H.P., Bergman M.P. Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes Infect. 2009, 11:988-994.
25. Park S.F., Richardson P.T. Molecular characterization of a Campylobacter jejuni lipoprotein with homology to periplasmic siderophore-binding proteins. J. Bacteriol. 1995, 177:2259-2264.
26. Parker C.T., Horn S.T., Gilbert M., Miller W.G., Woodward D.L., Mandrell R.E. Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources. J. Clin. Microbiol. 2005, 43:2771-2781.
27. Parker C.T., Gilbert M., Yuki N., Endtz H.P., Mandrell R.E. Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations. J. Bacteriol. 2008, 190:5681-5689.
28. Revez J., Rossi M., Ellström P., de Haan C., Rautelin H., Hänninen M.L. Finnish Campylobacter jejuni strains of multilocus sequence type ST-22 complex have two lineages with different characteristics. PLoS One 2011, 6:e26880.
29. Stahl M., Friis L.M., Nothaft H., Liu X., Li J., Szymanski C.M., Stintzi A. l-fucose utilization provides Campylobacter jejuni with a competitive advantage. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7194-7199.
30. Wassenaar T.M., Blaser M.J. Pathophysiology of Campylobacter jejuni infections of humans. Microbes Infect. 1999, 1:1023-1033.
31. Watson R.O., Galan J.E. Signal transduction in Campylobacter jejuni-induced cytokine production. Cell. Microbiol. 2005, 7:655-665.
32. Yang S.K., Eckmann L., Panja A., Kagnoff M.F. Differential and regulated expression of C-X-C, CC, and C-chemokines by human colon epithelial cells. Gastroenterology 1997, 113:1214-1223.
33. Zheng J., Meng J., Zhao S., Singh R., Song W. Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB. Infect. Immun. 2008, 76:4498-4508.